Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Streptococcus pneumoniae serotype 19F V-type ATP synthase subunit D (atpD) CSB-YP468403FNE
CSB-EP468403FNE
CSB-BP468403FNE
CSB-MP468403FNE
CSB-EP468403FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Adapter protein mecA (mecA) CSB-YP468404FNE
CSB-EP468404FNE
CSB-BP468404FNE
CSB-MP468404FNE
CSB-EP468404FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP468405FNE
CSB-EP468405FNE
CSB-BP468405FNE
CSB-MP468405FNE
CSB-EP468405FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Glutamine amidotransferase subunit pdxT (pdxT) CSB-YP468406FNE
CSB-EP468406FNE
CSB-BP468406FNE
CSB-MP468406FNE
CSB-EP468406FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP468407FNE
CSB-EP468407FNE
CSB-BP468407FNE
CSB-MP468407FNE
CSB-EP468407FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Transcription elongation factor GreA (greA) CSB-YP468408FNE
CSB-EP468408FNE
CSB-BP468408FNE
CSB-MP468408FNE
CSB-EP468408FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP468409FNE
CSB-EP468409FNE
CSB-BP468409FNE
CSB-MP468409FNE
CSB-EP468409FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F 30S ribosomal protein S19 (rpsS) CSB-YP468410FNE
CSB-EP468410FNE
CSB-BP468410FNE
CSB-MP468410FNE
CSB-EP468410FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F 50S ribosomal protein L6 (rplF) CSB-YP468411FNE
CSB-EP468411FNE
CSB-BP468411FNE
CSB-MP468411FNE
CSB-EP468411FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F 50S ribosomal protein L17 (rplQ) CSB-YP468412FNE
CSB-EP468412FNE
CSB-BP468412FNE
CSB-MP468412FNE
CSB-EP468412FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Ferredoxin--NADP reductase (SPG_1489) CSB-YP468413FNE
CSB-EP468413FNE
CSB-BP468413FNE
CSB-MP468413FNE
CSB-EP468413FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Cytidylate kinase (cmk) CSB-YP468414FNE
CSB-EP468414FNE
CSB-BP468414FNE
CSB-MP468414FNE
CSB-EP468414FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP468415FNE
CSB-EP468415FNE
CSB-BP468415FNE
CSB-MP468415FNE
CSB-EP468415FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Recombination protein RecR (recR) CSB-YP468416FNE
CSB-EP468416FNE
CSB-BP468416FNE
CSB-MP468416FNE
CSB-EP468416FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F Holliday junction resolvase recU (recU) CSB-YP468417FNE
CSB-EP468417FNE
CSB-BP468417FNE
CSB-MP468417FNE
CSB-EP468417FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae serotype 19F DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP468418FNE
CSB-EP468418FNE
CSB-BP468418FNE
CSB-MP468418FNE
CSB-EP468418FNE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter bemidjiensis N utilization substance protein B homolog (nusB) CSB-YP468419GFN
CSB-EP468419GFN
CSB-BP468419GFN
CSB-MP468419GFN
CSB-EP468419GFN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter bemidjiensis UPF0345 protein Gbem_3074 (Gbem_3074) CSB-YP468420GFN
CSB-EP468420GFN
CSB-BP468420GFN
CSB-MP468420GFN
CSB-EP468420GFN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter bemidjiensis 50S ribosomal protein L21 (rplU) CSB-YP468421GFN
CSB-EP468421GFN
CSB-BP468421GFN
CSB-MP468421GFN
CSB-EP468421GFN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacter bemidjiensis UPF0059 membrane protein Gbem_1700 (Gbem_1700), partial CSB-YP468422GFN1
CSB-EP468422GFN1
CSB-BP468422GFN1
CSB-MP468422GFN1
CSB-EP468422GFN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>